(Q33305306)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17988728%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

title

Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17988728%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

0 references

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17988728%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Marja-Riitta Taskinen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17988728%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17988728%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17988728%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

A C Keech

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17988728%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

P Mitchell

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17988728%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

P A Summanen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17988728%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

J O'Day

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17988728%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

M S Moffitt

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17988728%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

R J Simes

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17988728%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

D Tse

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17988728%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

A Merrifield

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17988728%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

L T Laatikainen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17988728%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

D C Crimet

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17988728%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

R L O'Connell

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17988728%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

P G Colman

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17988728%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

FIELD study investigators

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17988728%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

language of work or name

English

0 references

publication date

7 November 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17988728%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17988728%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

volume

370

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17988728%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

issue

9600

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17988728%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

page(s)

1687-1697

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17988728%20AND%20SRC:MED&resulttype=core&format=json

Current approaches and perspectives in the medical treatment of diabetic retinopathy.

9 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961607-9

7 January 2021

Laser treatment in diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961607-9

7 January 2021

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961607-9

7 January 2021

UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961607-9

7 January 2021

Photocoagulation for Diabetic Macular Edema

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961607-9

7 January 2021

Perspectives on diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961607-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961607-9

1 reference

7 January 2021

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961607-9

7 January 2021

Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy. Early Treatment Diabetic Retinopathy Study (ETDRS) Report 22.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961607-9

7 January 2021

Serum lipids and diabetic retinopathy. Early Treatment Diabetic Retinopathy Study Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961607-9

7 January 2021

The role of serum lipids in exudative diabetic maculopathy: is there a place for lipid lowering therapy?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961607-9

7 January 2021

Diabetic retinopathy and serum lipoprotein subclasses in the DCCT/EDIC cohort

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961607-9

7 January 2021

The importance of serum lipids in exudative diabetic macular edema in type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961607-9

7 January 2021

A prospective study of serum lipids and risk of diabetic macular edema in type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961607-9

7 January 2021

Low density lipoprotein cholesterol: an association with the severity of diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961607-9

7 January 2021

Long-term follow-up of and underlying medical conditions in patients with diabetic exudative maculopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961607-9

7 January 2021

Blood pressure, lipids, and obesity are associated with retinopathy: the hoorn study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961607-9

7 January 2021

Management of diabetic retinopathy: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961607-9

7 January 2021

Dyslipidaemia and microvascular disease in the retina

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961607-9

7 January 2021

Association of statin use with the risk of developing diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961607-9

7 January 2021

A double-blind controlled trial of clofibrate in the treatment of diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961607-9

7 January 2021

A three-year trial of atromid therapy in exudative diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961607-9

7 January 2021

Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961607-9

7 January 2021

Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study: baseline characteristics and short-term effects of fenofibrate [ISRCTN64783481]

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961607-9

7 January 2021

The effects of lipid lowering on diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961607-9

7 January 2021

Effect of atorvastatin on ocular blood flow velocities in patients with diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961607-9

7 January 2021

Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961607-9

7 January 2021

Vascular endothelial growth factor and diabetic retinopathy: role of oxidative stress

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961607-9

7 January 2021

Role of vascular endothelial growth factor in regulation of physiological angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961607-9

7 January 2021

Fenofibrate regulates retinal endothelial cell survival through the AMPK signal transduction pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961607-9

7 January 2021

Both fenofibrate and atorvastatin improve vascular reactivity in combined hyperlipidaemia (fenofibrate versus atorvastatin trial--FAT).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961607-9

7 January 2021

Serum inflammatory markers in diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961607-9

7 January 2021

Inhibition of TNF-alpha-induced RANTES expression in human hepatocyte-derived cells by fibrates, the hypolipidemic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961607-9

7 January 2021

PPAR activators inhibit endothelial cell migration by targeting Akt.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961607-9

7 January 2021

Determination of vitreous interleukin-1 (IL-1) and tumour necrosis factor (TNF) levels in proliferative diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961607-9

7 January 2021

Fenofibrate and pioglitazone improve endothelial function and reduce arterial stiffness in obese glucose tolerant men

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961607-9

7 January 2021

Malondialdehyde serum concentration in type 1 diabetic with and without retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961607-9

7 January 2021

Effect of simvastatin and fenofibrate on endothelium in Type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961607-9

7 January 2021

Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961607-9

7 January 2021

Lipid-lowering drugs and essential omega-6 and omega-3 fatty acids in patients with coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961607-9

7 January 2021

The metabolic syndrome: prevalence in worldwide populations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961607-9

7 January 2021

Effect of ruboxistaurin in patients with diabetic macular edema: thirty-month results of the randomized PKC-DMES clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961607-9

7 January 2021

The effect of ruboxistaurin on visual loss in patients with moderately severe to very severe nonproliferative diabetic retinopathy: initial results of the Protein Kinase C beta Inhibitor Diabetic Retinopathy Study (PKC-DRS) multicenter randomized cl

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961607-9

7 January 2021

Effect of ruboxistaurin on visual loss in patients with diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961607-9

7 January 2021

Rationale, design, and methods of the Action to Control Cardiovascular Risk in Diabetes Eye Study (ACCORD-EYE).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961607-9

7 January 2021

10.1016/S0140-6736(07)61607-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17988728%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17988728%20AND%20SRC:MED&resulttype=core&format=json